Funding for this research was provided by:
National Natural Science Foundation of China (81803258, 82003475, 81673198)
Jiangsu Province’s Science and Technology Project (BE2020722)
Received: 6 August 2022
Accepted: 1 November 2022
First Online: 17 November 2022
: The study was approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University and was performed in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The name of trial registration: Obesity-associated ophthalmopathy study.The number of trial registration: ChiCTR2000034371.Ethical ID: 2020-SR-315.URL: ExternalRef removed.Written informed consent was obtained from the parents or legal guardians of all children.
: Not applicable.
: The authors declare that there is no conflict of interest.